LNSR
LENSAR, Inc.
Set alert
- YTD
- -49.79%
- 1 year
- -51.54%
- Open
- 6.00
- Prev close
- 5.97
- Mkt cap
- 71.75M
- Vol
- 28.84K
- Avg vol
- 105.44K
- EPS
- 0.18
- P/E
- 32.44
- Div yield
- 0.00%
More statistics
- Low
- 5.76
- High
- 6.03
- Forward P/E
- -12.18
- Beta
- 0.58
- Short ratio
- 1.20
- Inst. own
- 42.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.72
- 200-d avg
- 4.84
- 1y target
- 11.00
Key statistics
- Market cap
- 100.47M
- Enterprise value
- 87.01M
- Trailing P/E
- 0.00
- Forward P/E
- -12.18
- PEG ratio
- 0.00
- Price / sales
- 2.06
- Price / book
- 4.42
- EPS (TTM)
- -1.46
- Beta
- 0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -34.03%
- Revenue (TTM)
- 48.87M
- Revenue growth
- 38.20%
- Free cash flow
- 0
- Total cash
- 18.08M
- Total debt
- 1.89M
- Return on equity
- -38.38%
- Shares outstanding
- 11.61M
- Short % of float
- 0.61%
- 50-day average
- 6.72
- 200-day average
- 4.84
Analyst view
Consensus: none
- Target (low)
- 10.00
- Target (mean)
- 11.00
- Target (high)
- 12.00
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.18.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.13 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.53 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.19 | — | — |
| Mar 4, 2024 | Dec 1, 2023 | 0.00 | -0.35 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.23 | — | — |
| Aug 9, 2023 | Jun 1, 2023 | 0.00 | -0.81 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 19, 2024 | Lake Street | init | — | Buy |
| Nov 22, 2021 | BTIG | init | — | Buy |
| Feb 24, 2021 | SVB Leerink | init | — | Outperform |
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- lensar.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LNSR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONNAUGHTON ALAN B. | Chief Operating Officer | Stock Award(Grant) | May 5, 2024 | 324,489 |
| CURTIS NICHOLAS T | Chief Executive Officer | Stock Award(Grant) | May 5, 2024 | 864,436 |
| ELLIS THOMAS B. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 6, 2024 | 1,131,880 |
| HAMMER TODD B. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 6, 2024 | 1,131,880 |
| LINDSTROM RICHARD L | Director | Stock Award(Grant) | May 6, 2024 | 239,036 |
| LINK WILLIAM J | Director | Stock Award(Grant) | May 6, 2024 | 543,267 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Park West Asset Management LLC | 8.52% | 989,945 | 8.56M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 5.59% | 648,959 | 5.61M | Sep 29, 2024 |
| Brandes Investment Partners L.P. | 3.82% | 443,398 | 3.84M | Sep 29, 2024 |
| Vanguard Group Inc | 3.73% | 433,474 | 3.75M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.65% | 307,945 | 2.66M | Sep 29, 2024 |
| DCF Advisers, LLC | 2.07% | 240,600 | 2.08M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44% | 282,930 | 2.45M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.15% | 133,235 | 1.15M | Sep 29, 2024 |
| DFA U.S. Targeted Value Portfolio | 1.00% | 116,724 | 1.01M | Jul 30, 2024 |
| DFA U.S. Small Cap Series | 0.88% | 102,775 | 889.00K | Jul 30, 2024 |
| DFA U.S. Small Cap Value Series | 0.86% | 100,409 | 868.54K | Jul 30, 2024 |
| Brandes Small Cap Value Fund | 0.81% | 94,178 | 814.64K | Sep 29, 2024 |